← Back to Search

Visual aid counseling for Induced Birth (VAIL Trial)

N/A
Recruiting
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes (during completion of survey)
Awards & highlights

VAIL Trial Summary

This trial seeks to create a visual aid tool that meets the needs of pregnant women, to help them feel more informed and satisfied with induction methods.

Who is the study for?
This trial is for English-speaking pregnant women scheduled for or admitted to labor induction, without major fetal anomalies, chromosomal issues, prior cesarean sections, already started inductions, terminations via induction, or fetal growth restrictions with doppler abnormalities.Check my eligibility
What is being tested?
The study is testing a new visual aid tool designed to educate about labor induction. It's based on input from historically marginalized pregnant women and aims to see if it improves their knowledge, satisfaction, and trust in doctors regarding induction methods.See study design
What are the potential side effects?
Since the intervention involves educational material rather than medication or medical procedures, there are no direct physical side effects expected from the visual aid itself.

VAIL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes (during completion of survey)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes (during completion of survey) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Induction of labor knowledge
Secondary outcome measures
Patient satisfaction
Patient trust in providers survey

VAIL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Visual aid counselingExperimental Treatment1 Intervention
Counseling on induction of labor with either a video or a handout
Group II: Standard counselingActive Control1 Intervention
Standard induction of labor counseling

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,611 Total Patients Enrolled

Media Library

Visual aid counseling Clinical Trial Eligibility Overview. Trial Name: NCT05671224 — N/A
Induced Birth Research Study Groups: Standard counseling, Visual aid counseling
Induced Birth Clinical Trial 2023: Visual aid counseling Highlights & Side Effects. Trial Name: NCT05671224 — N/A
Visual aid counseling 2023 Treatment Timeline for Medical Study. Trial Name: NCT05671224 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to enroll in this medical experiment?

"For this experiment, 84 people from 18 to 45 years old who have undergone a cesarean section are being sought for recruitment. Additionally, participants must be fluent in English and able to read and write fluently."

Answered by AI

Are there still opportunities for individuals to participate in this research experiment?

"As indicated on clinicaltrials.gov, this trial is still accepting participants and was most recently updated on August 9th 2023. It had been posted to the website a few months prior, on March 20th 2023."

Answered by AI

What is the aggregate patient population participating in this medical study?

"Affirmative. The information located on clinicaltrials.gov indicates that this medical trial is still accruing participants; the experiment was originally posted in March of 2023, and recently revised at the start of August. This study needs to fill 84 spots with patients from only one location."

Answered by AI

Are seniors over the age of fifty-five eligible for this research project?

"Per the study's entry requirements, only those between 18 and 45 years of age can take part in this clinical trial."

Answered by AI
~6 spots leftby Jun 2024